[29] [new] Analytical Performance Evaluation of Goldstream Fungus (1-3)-β-D Glucan.So MK, Huh J, Lee M, Kim SK. Clin Lab. 2022 May 1;68(5). doi: 10.7754/Clin.Lab.2021.210912. PMID: 35536073.

[28] Clinical Performance Evaluation of a Novel Monotest Galactomannan Detection in the Diagnosis of Invasive Aspergillosis. QQ Zhang. (2022) 10th Advances Against Aspergillosis and  Mucormycosis

[27] Evaluation of a Cryptococcus capsular polysaccharide detection FungiXpert LFA(lateral flow assay) for the rapid diagnosis of Cryptococcosis. Liu Y, Kang M, Wu SY, Wu LJ, et al. Medical Mycology, Volume 60, Issue 4, April 2022, myac020

[26] Lateral Flow Analysis Combinaed with Immunochromatofraphy Analyzer for Galactomannan Quantative Detection. (2022) ECCMID

[25] The Diagnostic Value of Fully Automatic Instrument for (1-3) -β-d-glucan Test in Patients with Tumour. (2022) ECCMID

[24] Research on the Diagnostic Performance of Several Different Galactomannan Methodologies for Invasive Aspergillosis. QQ Zhang. (2022) 10th Advances Against Aspergillosis and  Mucormycosis

[23] Neglecting Genetic Diversity Hinders Timely Diagnosis of Cryptococcus Infections. Shi D, Haas P J, Boekhout T, et al. Neglecting genetic diversity hinders timely diagnosis of Cryptococcus infections[J]. Journal of Clinical Microbiology, 2021.
[22] Evaluation of Carbapenem-Resistant K.N.I.V.O. Detection K-Set for the rapid detection of carbapenemases among carbapenem-resistant gram-negative bacilli. Session: 4. Diagnostic microbiology Category: 4a. Diagnostic bacteriology – culture based and general microbiology, from ECCMID 2022

[21] Evaluation of a Novel Diagnostic Method for Fungal Infection — (1,3)-β-D-Glucan Chemiluminescence Immunoassay. Lizhong Han. (2021) ECCMID, P1654.

[20] Full-Automatic Chemiluminescence Immunoassay System for Aspergillus Galactomannan Detection. Qiangqiang Zhang. (2021) ECCMID, P1651.

[19] The significance of combination detection of Aspergillus antigen and antibody lateral flow assay for invasive pulmonary aspergillosis diagnosis. Ruizhong Wang. (2021) ECCMID, P1652.

[18] The significance of combination detection of Candida mannan and antibody lateral flow assay for invasive candidiasis diagnosis. Xi Li. (2021) ECCMID, P1656.

[17] Prognostic values of serum galactomannan and  (1-3)-beta-D-glucan in hospitalised patients: analysis of initial and follow-up results. Park et al. (2019) ECCMID, P0131.

[16] Evaluation of CrAg lateral flow immunoassay for diagnosis of cryptococcal meningitis patients. Zhang Q. Q. (2018) ECCMID, P1198

[15] VALUTAZIONE DI DUE METODICHE PER IL DOSAGGIO SIERICO DEL 1,3-β-D-GLUCANO IN PAZIENTI A RISCHIO DI INFEZIONI FUNGINE INVASIVE. Cipriani R., Brossa S., Zanotto E. et al. (2017)

[14] VALUTAZIONE DI UN NUOVO TEST GOLDSTREAM FUNGUS (1,3)-?-D-Glucano PER LA DIAGNOSTICA DELLE INFEZIONI FUNGINE INVASIVE. De Nittis R., Delli Carri V., Trecca A. et al. (2017)

[13] Diagnostic performance of the (1-3)-β-D-glucan assay in patients with Pneumocystis jirovecii compared with those with candidiasis, aspergillosis, mucormycosis, and tuberculosis, and healthy volunteers. Son H J, Sung H, Park S Y, et al., (2017), PLoS One. 2017 Nov 30;12(11):e0188860. 

[12] Diagnostic Performance of the (1–3)-β-D-Glucan Assay in Pneumocystitis jirovecii, Invasive Aspergillosis, Mucormycosis, Tuberculosis and Healthy Volunteers. Son H J, Sung H, Park S Y, et al., (2016), Open Forum Infectious Diseases. Oxford University Press, 3(suppl 1): 1562.

[11] New galactomannan assay for invasive aspergillus diagnosis in high risk patients received anti-cancer therapies in China. Zhang, P., Zhang, W., Li, D. (2016) American Society for Microbiology

[10] Statistical assessment of Tachypleus amoebocyte lysate for early diagnosis of invasive fungal disease at an ICU in China. Qin, Z., Y Ji., Zhang, A., D., LI, J., Liu, D., Wang, Z., Y., Wang, C., X. (2016) ECCMID

[9] Emergence of TR46/Y121F/T289A in an Aspergillus fumigatus Isolate from a Chinese Patient. Chen Y, Wang H, Lu Z, et al., (2015), Antimicrobial Agents & Chemotherapy, 59(11):7148.

[8] Serum Levels of Lipopolysaccharide and 1, 3-β-D-Glucan Refer to the Severity in Patients with Crohn’s Disease. Guo Y, Zhou G, He C, et al., (2015), Mediators of inflammation

[7] The screening performance of serum 1, 3-beta-D-glucan in patients with invasive fungal diseases: a meta-analysis of prospective cohort studies. Hou, T., Y., Wang, S., H., Liang, S., X., Jiang, W., X., Luo, D., D., Huang, D., H, (2015) PLoS ONE 10(7): e0131602.

[6] Platelet parameters and (1, 3)-β -D-glucan as a diagnostic and prognostic marker of invasive fungal disease in preterm infants. Zhao, D., Y., Qiu, G., Luo, Z., C., Zhang, Y., J. (2015). PLoS ONE 10(4): e0123907.

[5] Evaluation of a novel plasma (1, 3)-β-d-glucan detection assay for diagnosis of candidemia in pediatric patients. Liu, Y., Chen, F., Zhu, X., Shen, L., & Zhang, S. X. (2015). Journal of Clinical Microbiology, 53(9), 3017-3020.

[4] The serum glucan level and pathological changes of antifungal treatment for lower respiratory tract infection of Candida albicans. Xu W M, Shui W, Lin J C, et al. Medical mycology, (2014): myu068.

[3] Risk factors for recurrence of invasive fungal infection during secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients. Liu F, Wu T, Wang J B, et al., (2013), Transplant Infectious Disease, 15(3): 243-250.

[2] Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome. Barton, R., C. (2013) Scientifica

[1] Diagnostic accuracy of serum 1, 3-β-d-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis. Onishi, A., Sugiyama, D., Kogata, Y., Saegusa, J., Sugimoto, T., & Kawano, S., et al. (2012) Journal of Clinical Microbiology, 50(1), 7-15.